Literature DB >> 16461319

The involvement of cellular proliferation status in the expression of the human proto-oncogene DEK.

Malin Ageberg, Urban Gullberg, Anders Lindmark.   

Abstract

The role of the DEK protein, involved in the leukemia-associated fusion protein DEK-CAN, is not yet known. In this study, we show a higher expression of DEK mRNA in immature cells than in mature cells. Furthermore, a correlation between DEK expression and cell proliferation was demonstrated, suggesting that DEK plays a role in the proliferation of hematopoietic cells and raising the question of whether the DEK-CAN fusion protein might perturb regulation of proliferation in leukemic cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461319

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  14 in total

Review 1.  Control of tumorigenesis and chemoresistance by the DEK oncogene.

Authors:  Erica Riveiro-Falkenbach; María S Soengas
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

Review 2.  The DEK oncoprotein and its emerging roles in gene regulation.

Authors:  C Sandén; U Gullberg
Journal:  Leukemia       Date:  2015-03-13       Impact factor: 11.528

3.  Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status.

Authors:  Dong-Mei Wang; Ling Liu; Lei Fan; Zhi-Jian Zou; Li-Na Zhang; Shu Yang; Jian-Yong Li; Wei Xu
Journal:  Cancer Biol Ther       Date:  2012-10-10       Impact factor: 4.742

4.  Loss of DEK induces radioresistance of murine restricted hematopoietic progenitors.

Authors:  Juana Serrano-Lopez; Kalpana Nattamai; Nicholas A Pease; Miranda S Shephard; Ashley M Wellendorf; Mathieu Sertorio; Eric A Smith; Hartmut Geiger; Susanne I Wells; Jose A Cancelas; Lisa M Privette Vinnedge
Journal:  Exp Hematol       Date:  2017-12-27       Impact factor: 3.084

Review 5.  A role for intracellular and extracellular DEK in regulating hematopoiesis.

Authors:  Maegan L Capitano; Hal E Broxmeyer
Journal:  Curr Opin Hematol       Date:  2017-07       Impact factor: 3.284

6.  DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.

Authors:  F Kappes; J Fahrer; M S Khodadoust; A Tabbert; C Strasser; N Mor-Vaknin; M Moreno-Villanueva; A Bürkle; D M Markovitz; E Ferrando-May
Journal:  Mol Cell Biol       Date:  2008-03-10       Impact factor: 4.272

Review 7.  Concise review: role of DEK in stem/progenitor cell biology.

Authors:  Hal E Broxmeyer; Nirit Mor-Vaknin; Ferdinand Kappes; Maureen Legendre; Anjan K Saha; Xuan Ou; Heather O'Leary; Maegan Capitano; Scott Cooper; David M Markovitz
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

Review 8.  Molecular regulation of stem cell quiescence.

Authors:  Tom H Cheung; Thomas A Rando
Journal:  Nat Rev Mol Cell Biol       Date:  2013-06       Impact factor: 94.444

9.  The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer.

Authors:  Lisa M Privette Vinnedge; Shuk-Mei Ho; Kathryn A Wikenheiser-Brokamp; Susanne I Wells
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

10.  The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.

Authors:  Carl Sandén; Linnea Järvstråt; Andreas Lennartsson; Per Ludvik Brattås; Björn Nilsson; Urban Gullberg
Journal:  Mol Cancer       Date:  2014-09-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.